CNADF (CanadaBis Capital) Operating Margin %: 3.65% (As of Oct. 2025) — Near Median


What is CanadaBis Capital Operating Margin %?

CanadaBis Capital CNADF -89.50% Operating Margin % is 3.65% as of Oct. 2025, which is 1% below its 10-year median of 3.67. The stock has 6 warning signs investors should review. Among 955 Drug Manufacturers companies, CanadaBis Capital ranks worse than 68.17% on this metric.

Operating Margin % is calculated as Operating Income divided by its Revenue. CanadaBis Capital's Operating Income for the three months ended in Oct. 2025 was $0.09 Mil. CanadaBis Capital's Revenue for the three months ended in Oct. 2025 was $2.33 Mil. Therefore, CanadaBis Capital's Operating Margin % for the quarter that ended in Oct. 2025 was 3.65%.

The historical rank and industry rank for CanadaBis Capital's Operating Margin % or its related term are showing as below:

CNADF' s Operating Margin % Range Over the Past 10 Years
Min: -106.57   Med: 3.67   Max: 21.05
Current: 1.02


CNADF's Operating Margin % is ranked worse than
68.17% of 955 companies
in the Drug Manufacturers industry
Industry Median: 7.45 vs CNADF: 1.02

CanadaBis Capital's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

CanadaBis Capital's Operating Income for the three months ended in Oct. 2025 was $0.09 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Oct. 2025 was $0.10 Mil.


CanadaBis Capital  (OTCPK:CNADF) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


CanadaBis Capital Operating Margin % Related Terms


CanadaBis Capital Operating Margin % Historical Data

* Premium members only.

The historical data trend for CanadaBis Capital's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CanadaBis Capital Operating Margin % Chart

CanadaBis Capital Annual Data
Trend Nov16 Dec17 Dec18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -33.28 8.89 21.05 4.64 2.69

CanadaBis Capital Quarterly Data
Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.25 3.87 4.23 -7.94 3.65

CNADF vs ZTS: Operating Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, CanadaBis Capital's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CanadaBis Capital Operating Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CanadaBis Capital's Operating Margin % distribution charts can be found below:

* The bar in red indicates where CanadaBis Capital's Operating Margin % falls into.



CanadaBis Capital Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

CanadaBis Capital's Operating Margin % for the fiscal year that ended in Jul. 2025 is calculated as

Operating Margin %=Operating Income (A: Jul. 2025 ) / Revenue (A: Jul. 2025 )
=0.332 / 12.345
=2.69 %

CanadaBis Capital's Operating Margin % for the quarter that ended in Oct. 2025 is calculated as

Operating Margin %=Operating Income (Q: Oct. 2025 ) / Revenue (Q: Oct. 2025 )
=0.085 / 2.331
=3.65 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Margin % →
What does a Operating Margin % of 3.65% mean?
CanadaBis Capital (CNADF) has a Operating Margin % of 3.65% as of Oct. 2025. Operating margin is the ratio of total operating income to net sales. View historical data on CanadaBis Capital and its competitors. This is near median its historical median of 3.67. According to the industry distribution chart, CanadaBis Capital ranks #651 out of 955 companies in the Drug Manufacturers industry, placing it in the top 68.2%.
Is CanadaBis Capital's Operating Margin % too high?
CanadaBis Capital's current Operating Margin % of 3.65% is near median its 10-year median of 3.67. The Drug Manufacturers industry median Operating Margin % is 7.45. CanadaBis Capital's value of 3.65% is 51% below this industry median. Based on the distribution chart, CanadaBis Capital ranks #651 out of 955 companies in the Drug Manufacturers industry, which is below the industry midpoint.
How does CanadaBis Capital's Operating Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, CanadaBis Capital ranks #651 out of 955 companies for Operating Margin %. This places CanadaBis Capital in the lower half of its industry. The industry median Operating Margin % is 7.45. CanadaBis Capital's value of 3.65% is 51% below this benchmark. While the company's 10-year median is 3.67 vs. the industry median of 7.45, CanadaBis Capital has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Drug Manufacturers company?
The median Operating Margin % among Drug Manufacturers companies is 7.45, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CanadaBis Capital's current Operating Margin % of 3.65% is 51% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on CanadaBis Capital and its competitors. For the Drug Manufacturers industry, the median Operating Margin % is 7.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CanadaBis Capital's current Operating Margin % is 3.65%, which is near median its own 10-year median of 3.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CanadaBis Capital stock overvalued right now?
CanadaBis Capital (CNADF) has a current Operating Margin % of 3.65%. The current Operating Margin % is 3.65%, which is near median its 10-year median of 3.67 and 51% below the Drug Manufacturers industry median of 7.45. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For CanadaBis Capital (CNADF), the current Operating Margin % is 3.65% as of Oct. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CanadaBis Capital Business Description

Address 255C Clearview Drive, Red Deer County, Red Deer, AB, CAN, T4E 3B6
CanadaBis Capital Inc is a vertically integrated cannabis company. The firm engages in the production and sale of recreational cannabis. Its product line consists of Stigma Roots. It operates in three segments: wholesale, retail, and extract. The wholesale segment cultivates and distributes cannabis and cannabis products to and through, provincial liquor and cannabis boards. Retail segment involves sale of cannabis and cannabis-related products to end consumers on-premises owned and operated by the Company. Extract segment provides cannabinoid extraction services to other licensed producers. The company generates maximum of its revenue from Extract Segment.